REQUEST A DEMO
Total
USD $0.00
Search more companies

Kopran Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Kopran Ltd. Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Kopran Ltd. is an integrated Pharmaceutical Company located in Mumbai, Maharashtra, India. It is a group company of Parijat Enterprises and is committed to manufacturing and supplying international quality formulations and active pharmaceutical ingredients worldwide. Kopran manufactures a wide range of products, including both active pharmaceutical ingredients and finished dosage forms. Its manufacturing facilities and products have accreditations in all continents and are approved by various regulatory authorities. Kopran focuses on improving technology and developing new products through its sophisticated research and development department. The company offers a range of APIs, including sterile cephalosporins, as well as specialty products such as macrolides, anticonvulsants, and cardiovascular drugs. In terms of formulations, Kopran provides over 100 dosage forms, including tablets, capsules, dry powder, suspension, and injectables.

Legal Address
Parijat House , 1076, Dr. E. Moses Road, Worli
Mumbai; Maharashtra; Postal Code: 400018

Contact Details: Purchase the Kopran Ltd. report to view the information.

Website: http://www.kopran.com

Basic Information
Total Employees:
Purchase the Kopran Ltd. report to view the information.
Outstanding Shares:
Purchase the Kopran Ltd. report to view the information.
Registered Capital:
Purchase the Kopran Ltd. report to view the information.
Financial Auditors:
Purchase the Kopran Ltd. report to view the information.
Incorporation Date:
1958
Key Executives
Purchase this report to view the information.
Executive Vice Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Additional Director
Ownership Details
Purchase this report to view the information.
44.49%
Purchase this report to view the information.
40.74%
Purchase this report to view the information.
13.23%
Purchase this report to view the information.
1.32%
Purchase this report to view the information.
0.22%
Subsidiaries
Kopran (HK) Ltd.
100%
Kopran Lifesciences Ltd.
100%
Kopran Research Laboratories Limited
99.5%
Company Performance
Financial values in the chart are available after Kopran Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
19.18%
Total operating revenue
19.18%
Operating profit (EBIT)
368.52%
EBITDA
187.8%
Net Profit (Loss) for the Period
300.72%
Total equity
0%
Operating Profit Margin (ROS)
7.64%
Net Profit Margin
5.59%
Return on Equity (ROE)
17.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?